BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaewput C, Vinjamuri S. Role of Combined 68Ga DOTA-Peptides and 18F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms. Diagnostics 2022;12:280. [DOI: 10.3390/diagnostics12020280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Castle JT, Levy BE, Chauhan A. Pediatric Neuroendocrine Neoplasms: Rare Malignancies with Incredible Variability. Cancers (Basel) 2022;14:5049. [PMID: 36291833 DOI: 10.3390/cancers14205049] [Reference Citation Analysis]
2 Urso L, Panareo S, Castello A, Ambrosio MR, Zatelli MC, Caracciolo M, Tonini E, Valpiani G, Boschi A, Uccelli L, Cittanti C, Bartolomei M. Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial. Pharmaceutics 2022;14:2009. [DOI: 10.3390/pharmaceutics14102009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Nosov NA, Popov SA, Rozengauz EV, Stanzhevskii AA, Mus VF, Maystrenko DN. <sup>68</sup>Ga-DOTATATE PET/CT Capabilities in Diagnosing of Neuroendocrine Tumors Recurrence. jour 2022;5:18-28. [DOI: 10.37174/2587-7593-2022-5-3-18-28] [Reference Citation Analysis]